Eli Lilly and Company (LLY)
Live and historical stock data for Eli Lilly and Company, delivered through Axion's financial data API - pricing, fundamentals, SEC filings, ownership, ETF exposure and sentiment in one JSON response.
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lis…
GET /stocks/LLY/pricesLLY Price History
Weekly close prices for Eli Lilly and Company, pulled directly from Axion's historical market data API.
LLY Fundamentals - Financial Analytics API
Multi-year Eli Lilly and Company financial statement data, structured for a quantitative finance API workflow - no PDF parsing or scraping required.
GET /financials/LLY/revenueRevenue & Net Income
Annual revenue vs. net income, sourced from SEC filings.
- Net Income
- Revenue
GET /financials/LLY/cashflow/freeFree Cash Flow vs. CapEx
Cash generated after operating costs vs. capital reinvested into the business.
- CapEx
- Free Cash Flow
GET /financials/LLY/epsEPS Trend (TTM)
Trailing twelve-month earnings per share, by report date.
GET /financials/LLY/roe · /deProfitability & Leverage
Return on equity vs. debt-to-equity, by report date.
- Debt/Equity
- ROE
LLY Valuation - Investment Research API
DCF fair value, analyst consensus and the 52-week trading range for LLY, built for investment research API and trading data API use cases.
GET /financials/dcf/LLY/valueMargin of safety: 0.0%
GET /profiles/LLY/summary52W Range: $623.78 - $1,238.00
GET /profiles/LLY/recommendationAnalyst Consensus Trend
Strong buy / buy / hold / sell counts across recent trailing periods.
- Buy
- Hold
- Sell
- Strong Buy
ETF & Fund Exposure to LLY
Every mutual fund and ETF reporting a position in LLY, searchable by fund name - a direct look at institutional financial data API coverage for this ticker.
GET /insiders/LLY/funds| Fund / ETF | Shares Held | % Held | Value |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | - | 2.9% | $32.34B |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | - | 2.1% | $24.15B |
| iShares Trust-iShares Core S&P 500 ETF | - | 1.1% | $12.29B |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | - | 1.1% | $12.16B |
| GROWTH FUND OF AMERICA | - | 1.1% | $12.01B |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | - | 1.0% | $11.46B |
| VANGUARD INDEX FUNDS-Vanguard Growth Index Fund | - | 0.9% | $10.76B |
| INVESTMENT CO OF AMERICA | - | 0.6% | $7.27B |
| SELECT SECTOR SPDR TRT-State Street Health Care Select Sector SPDR ETF | - | 0.6% | $6.61B |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | - | 0.6% | $6.53B |
Companies Linked to LLY - Trading Data API
Peers, suppliers and customers mapped from Axion's supply chain API, useful for building correlated, cross-company trading data API signals.
- Eli Lilly And CompanyLLY
- Corning IncGLW
- Dow IncDOW
- Eastman Chemical CoEMN
- Scully Royalty LtdSRL
- Piedmont Lithium IncPLL
- Petco Health And Wellness Company IncWOOF
- Aflac IncorporatedAFL
- Assurant IncAIZ
- Axis Capital Holdings LimitedAXS
- The Cigna GroupCI
- Tenaya Therapeutics, Inc.TNYA
- Biomea Fusion IncBMEA
- CNS Pharmaceuticals, Inc.CNSP
- NanoViricides, Inc.NNVC
- Genprex IncGNPX
- Neumora Therapeutics, Inc.NMRA
LLY Ownership - Institutional Financial Data API
Insider, institutional and public ownership breakdown, plus the latest insider transactions.
GET /insiders/LLY/ownership- Insiders
- Institutions
- Public / Other
| Insider | Activity | Shares | Value |
|---|---|---|---|
| ALVAREZ RALPH | Stock Award(Grant) at price 1129.35 per share. | 10 | $12.4K |
| SULZBERGER GABRIELLE | Stock Award(Grant) at price 1129.35 per share. | 4 | $5.0K |
| FYRWALD J. ERIK | Stock Award(Grant) at price 1129.35 per share. | 8 | $9.9K |
| LUCIANO JUAN R | Stock Award(Grant) at price 1129.35 per share. | 14 | $15.9K |
| YUFFA ILYA | Sale at price 1150.77 per share. | 2.5K | $2.88M |
LLY ESG Scores
Environmental, social, governance and controversy scores, pulled from the same financial data API.
GET /esg/LLYESG Score Breakdown
LLY Market Sentiment - Financial Intelligence API
News, social and analyst sentiment for LLY, refreshed continuously.
GET /sentiment/LLY/newsGET /sentiment/LLY/socialGET /sentiment/LLY/analystGET /filings/LLYRecent SEC Filings
- 4Aug 11, 2026
- 144Aug 10, 2026
- 4Aug 10, 2026
- 144Aug 7, 2026
- 10-QAug 5, 2026
GET /news/LLYLatest News
- Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - Reuters Wed, 12 Aug 2026 23:09:19 GMT
- Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale - BioSpace Thu, 13 Aug 2026 11:25:58 GMT
- Eli Lilly Stock Nears Buy Point After Earnings-Fueled Gains - Investor's Business Daily Fri, 14 Aug 2026 12:00:00 GMT
- Eli Lilly sues Mounjaro/Zepbound generics as GLP-1 disputes multiply - IAM Patent Fri, 14 Aug 2026 13:08:51 GMT
- Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market? - Yahoo Finance Tue, 11 Aug 2026 12:44:16 GMT
See It In Action - API & Python Example
The same request that powers this page, in cURL, Python and JavaScript, plus an example chart rendered straight from the response.
curl https://api.axionquant.com/stocks/LLY/quote \
-H "Authorization: Bearer YOUR_API_KEY"GET /financials/LLY/revenueRendered from the response above
Revenue vs. net income - the exact data returned by the Python example.
- Historical prices (OHLCV)
- Financial statements & ratios
- DCF valuation & analyst consensus
- Insider & institutional ownership
- ETF & fund exposure
- ESG scores
- Supply chain & peers
- SEC filings
- News, social & analyst sentiment
- Company news
Why Developers Use Axion's Financial Data API
A single stock market API and market data API for pricing, fundamentals and alternative data - built for quant research API and institutional financial data API workflows.
One API, every asset class
Equities, ETFs, crypto, forex and futures through a single financial data API - no juggling vendors.
Institutional-grade fundamentals
Point-in-time financial statements sourced from SEC filings, built for an institutional financial data API workflow.
Built for backtesting
Daily and weekly historical market data going back years, ready for a quantitative finance API pipeline.
Alternative data included
ESG, sentiment, supply chain and insider activity - a financial intelligence API that goes beyond price.
Free tier, real docs
Explore the stock data API for free - grab a key and start pulling market data in minutes.
Research You Can Build on LLY
Starting points for quant research API and investment research API projects using this ticker.
Backtest a strategy on LLY
Pull LLY's full daily price history and combine it with fundamentals to backtest momentum or mean-reversion signals.
Build a DCF valuation model
Feed live revenue, free cash flow and discount-rate inputs into your own model, benchmarked against Axion's DCF fair value.
Screen for Health Technology peers
Use supply-chain and sector classification data to build a comparable-company screen around LLY.
Factor in ESG and sentiment
Combine ESG scores with news and social sentiment to test alternative-data factors against returns.
Track insider conviction
Monitor insider buying and selling activity, plus ETF and institutional ownership shifts, ahead of catalysts.
Map supply-chain risk
Trace LLY's suppliers and customers to model second-order exposure to sector shocks.
Explore More From Axion
One account, every dataset - browse the rest of Axion's market data API and alternative data catalog.
Built for Teams Like These
From independent researchers to institutional desks - Axion powers financial applications at every scale.
LLY Data, Built for Developers and Quant Teams
Eli Lilly and Company pricing, fundamentals and alternative data are available through Axion's financial data API - a single, consistent stock data API and market data API covering equities, ETFs, crypto, forex and futures. Instead of stitching together a stock market API for pricing, a separate SEC filings feed, and a spreadsheet for fundamentals, pull LLY's revenue, EPS, insider activity, ETF exposure, ESG scores and DCF valuation from one financial analytics API.
Axion is built for institutional financial data API and quant research API workflows: point-in-time financial statements for backtesting, a historical market data API with daily and weekly granularity going back years, and an investment research API layer that surfaces analyst consensus, sentiment and ownership changes for LLY alongside every other ticker you track. Whether you're building a quantitative finance API pipeline, a trading data API for a systematic strategy, or a research dashboard, LLY's complete dataset is one authenticated request away.
Frequently asked questions
Does Axion offer a stock market API for LLY?
Yes. Axion's stock data API returns real-time quotes, historical prices, fundamentals, SEC filings, ownership and sentiment for LLY through a single financial data API key.
Can I pull LLY's historical market data programmatically?
Yes - the historical market data API returns daily, weekly, monthly, quarterly or yearly OHLCV bars for LLY, with no fixed lookback limit.
Is LLY's fundamental data suitable for quant research?
Yes. Revenue, net income, free cash flow, ROE and DCF valuation are exposed as structured JSON, ready for a quantitative finance API or quant research API pipeline - no scraping or PDF parsing required.
Can I see which ETFs and funds hold LLY?
Yes. Axion's institutional financial data API includes fund and ETF ownership, insider transactions and major-holder breakdowns for LLY, refreshed alongside SEC filings.